Dublin, Nov. 22, 2018 (GLOBE NEWSWIRE) — The “Apoptosis Assays Market by Product, Detection Technology, Application – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%.
The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are the key drivers for market growth. However, high investments required for research and development is expected to restrain the growth of this market to a certain extent during the forecast period.
On the basis of detection technology, the apoptosis assays market is segmented into flow cytometry, cell imaging & microscopy, spectrophotometry, and other detection technologies. The cell imaging & microscopy segment is expected to register the highest CAGR during the forecast period. The increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research is the major factor driving the growth of this market segment.
On the basis of application, the apoptosis assays market is segmented into drug discovery & development, basic research, stem cell research, and clinical & diagnostic application. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research. Also government initiatives are expected to increase the number of cell-based research activities, which in turn will support the growth of the stem cell application segment.
North America is expected to account for the largest share of the global apoptosis assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.
Key Topics Covered:
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Apoptosis Assays Market Overview
4.2 Apoptosis Assays Market: Geographic Overview (2017)
4.3 Regional Mix: Apoptosis Assays Market (2018-2023)
4.4 Asia Pacific: Apoptosis Assays Market, By End User & Country (2017)
4.5 Apoptosis Assays Market: Developed vs Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence and Prevalence of Chronic and Infectious Diseases
5.2.1.2 Growing Funding for Cancer Research
5.2.1.3 Growing Cell-Based Research
5.2.1.4 Development of Apoptosis-Modulating Drugs
5.2.2 Restraints
5.2.2.1 High Investments Required for Research and Development
5.2.3 Opportunities
5.2.3.1 Emerging Markets
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Adoption of Apoptosis-Targeting Therapy in Cancer Treatment
6.2.2 Technological Advancements
6.2.2.1 Label-Free Detection and Imaging of Apoptosis
6.2.2.2 Microfluidic Devices for the Analysis of Apoptosis
6.3 Unmet Need
6.3.1 Unavailability of 3D Apoptosis Assays
7 Apoptosis Assays Market, By Product
7.1 Introduction
7.1.1 Assay Kits
7.1.1.1 Caspase assays
7.1.1.1.1 Caspase Assays to Dominate the Assay Kits Market During the Forecast Period
7.1.1.2 Annexin V and Cell Permeability Assays
7.1.1.2.1 Annexin V & Cell Permeability Assays are Among the Most Commonly Used Apoptosis Assays Due to Their Ability to Bind to Phosphatidylserine
7.1.1.3 DNA Fragmentation Assays
7.1.1.3.1 Ability to Detect Nuclear Changes to Drive the Demand for DNA Fragmentation Assay Kits
7.1.1.4 Mitochondrial Assays
7.1.1.4.1 Merck, Thermo Fisher, Bio-Rad, and BD are Among the Key Players in the Mitochondrial Assays Segment
7.1.2 Reagents
7.1.3 Instruments
7.1.4 Microplates
8 Apoptosis Assays Market, By Detection Technology
8.1 Introduction
8.1.1 Flow Cytometry
8.1.1.1 Flow Cytometry is the Most Popular Apoptosis Detection Technology Owing to Its Ability to Provide Quantitative Multi-Parametric Analysis
8.1.2 Cell Imaging and Microscopy
8.1.2.1 Ability to Monitor Cell Physiology and Examine Complex Cellular Processes to Drive the Demand for Cell Imaging and Microscopy Technologies
8.1.3 Spectrophotometry
8.1.3.1 Lower Instrument Cost as Compared to Flow Cytometers Drives Greater Adoption of Spectrophotometers in Academic Settings
8.1.4 Other Detection Technologies
9 Apoptosis Assays Market, By Application
9.1 Introduction
9.2 Drug Discovery and Development
9.2.1 Drug Discovery and Development Forms the Largest Application Market for Apoptosis Assays
9.3 Clinical and Diagnostic Applications
9.3.1 Rising Prevalence of Cancer, Blood-Related Disorders, & Infectious Diseases Driving the Demand for Apoptosis Assays for Clinical & Diagnostics Applications
9.4 Basic Research
9.4.1 Growing Research Funding for Academic Institutions Likely to Support the Demand for Apoptosis Assays in Basic Research
9.5 Stem Cell Research
9.5.1 Rapidly Growing Interest in Regenerative Therapies Driving the Demand for Apoptosis Assays in Stem Cell Research
10 Apoptosis Assays Market, By End User
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
10.2.1 Rising R&D Activities & Interest Towards Development of Apoptosis Targeted Therapies Likely to Drive the Market Growth Among Pharmaceutical & Biotechnology Companies
10.3 Hospital & Diagnostic Laboratories
10.3.1 Increasing Number of Hospitals & High Prevalence of Chronic Diseases to Drive the Market Growth Among Hospital & Diagnostic Laboratories
10.4 Academic & Research Institutes
10.4.1 Growing Drug Discovery Research in Academic Institutions to Propel the Demand for Apoptosis Assays
11 Apoptosis Assays Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 Increasing Demand for Early and Effective Disease Diagnosis and Treatment to Drive the Growth of the Apoptosis Assays Market in the Us
11.2.2 Canada
11.2.2.1 Number of Government Initiatives to Support Life Sciences Research to Drive the Apoptosis Assays Market in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Well-Established R&D Infrastructure & Large Number of Academic Research Institutes Account for Large Share of Germany in European Apoptosis Assays Market
11.3.2 France
11.3.2.1 Support From Government and Private Investors for Promoting Research in Cell Therapy to Drive the Growth of the Apoptosis Assays Market in France
11.3.3 UK
11.3.3.1 Growing Prevalence of Cancer and Neurological Disorders & Increasing R&D Investments to Drive the Demand for Apoptosis Assays in the UK
11.3.4 Italy
11.3.4.1 Increasing Prevalence of Target Diseases Driving the Demand for Apoptosis Assays in Italy
11.3.5 Spain
11.3.5.1 Increasing Private and Public Funding for Cell-Based Research to Drive the Growth of the Apoptosis Assays Market in Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.1.1 High Prevalence of Cancer and Expansion of Cancer Research to Drive the Growth of the Apoptosis Assays Market in Japan
11.4.2 China
11.4.2.1 Increasing Prevalence of Chronic Diseases and Expanding Biopharmaceutical Research Propelling the Growth of the Apoptosis Assays Market in China
11.4.3 India
11.4.3.1 Geographic Expansion of Pharmaceutical Companies and Increasing Cell-Based Research Expected to Drive the Demand for Apoptosis Assays in India
11.4.4 Rest of Asia Pacific
11.5 Latin America
11.5.1 Increasing Funding for Life Sciences Research to Drive the Demand for Apoptosis Assays in Latin America
11.6 Middle East & Africa
11.6.1 Increasing Number of Partnerships in the Research Sector Driving the Market Growth in the Middle East & Africa
12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.2.1 Market Share Analysis: Apoptosis Assay Kits Market
12.3 Competitive Situation and Trends
12.3.1 Product Launches
12.3.2 Expansions
12.3.3 Acquisitions
12.3.4 Other Strategies
13 Company Profiles
- Abcam PLC
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Bio-Techne Corporation
- Biotek Instruments
- Biotium
- Creative Bioarray (A Part of Creative Dynamics Inc.)
- Danaher Corporation
- GE Healthcare
- GeneCopoeia, Inc.
- Geno Technology, Inc.
- Merck KGaA
- PerkinElmer
- Promega Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/research/q889k5/apoptosis_assays?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs
